Previous Close | 52.51 |
1-Year Change | 309.59% |
6-Months Change | 352.67% |
3-Months Change | 47.92% |
Moving Avg (50d) | 47.155 |
Moving Avg (200d) | 25.21 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.84B |
Beta (3-Years) | 0.83 |
Revenue Growth (ttm) | 29.07% |
Net Profit Margin (ttm) | -12.44% |
Return On Assets (ttm) | -4.97% |
EPS (ttm) | -0.45 |
PE Ratio (ttm) | -116.69 |
Dividend Yield | % |
Asset Description: | Harrow Health, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-11-20 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
42.042 | 40.755 | 39.897 | 38.61 | 36.465 | 34.32 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Pharmaceuticals |
Country: | United States |